🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a phase 1, double-blind, placebo-controlled crossover study o...
Status
Completed
Location
Sage Investigational Site
Start Date
2018-09-24
Trial ID
NCT03771586
The primary purpose of this study is to evaluate the effect of SAGE-718 on ...
Status
Completed
Location
Sage Investigational Site
Start Date
2022-01-26
Trial ID
NCT05107128
This study is a Phase 1, randomized, double-blind, placebo-controlled study...
Status
Completed
Location
Sage Investigational Site
Start Date
2018-12-27
Trial ID
NCT03844906
This study is a phase 1, double-blind, placebo-controlled, multiple ascendi...
Status
Completed
Location
Sage Investigational Site
Start Date
2019-02-28
Trial ID
NCT03787758
Treatments Being Tested
The primary purpose of this study is to assess the magnitude of the baselin...
Status
Completed
Location
Sage Investigational Site
Start Date
2022-05-26
Trial ID
NCT05358821
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
Sage Investigational Site
Start Date
2020-12-07
Trial ID
NCT04602624
Treatments Being Tested
The primary purpose of the study is to evaluate the safety and tolerability...
Status
Terminated
Location
Sage Investigational Site
Start Date
2022-12-14
Trial ID
NCT05655520
Treatments Being Tested
This study is a phase 1, double-blind, placebo-controlled crossover study o...
Status
Completed
Location
Sage Investigational Site
Start Date
2018-11-12
Trial ID
NCT03770780
The primary purpose of this two-part study was to evaluate the safety and t...
Status
Completed
Location
Sage Investigational Site
Start Date
2020-07-31
Trial ID
NCT04476017
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of SAGE-718 on ...
Status
Completed
Location
Sage Investigational Site
Start Date
2022-11-29
Trial ID
NCT05619692
Treatments Being Tested